CN112438943A - 一种复方鱼肝油氧化锌软膏 - Google Patents

一种复方鱼肝油氧化锌软膏 Download PDF

Info

Publication number
CN112438943A
CN112438943A CN201910751576.4A CN201910751576A CN112438943A CN 112438943 A CN112438943 A CN 112438943A CN 201910751576 A CN201910751576 A CN 201910751576A CN 112438943 A CN112438943 A CN 112438943A
Authority
CN
China
Prior art keywords
zinc oxide
liver oil
ointment
compound
cod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910751576.4A
Other languages
English (en)
Inventor
刘欣
张瑜
杨柳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Kingyork Pharmaceutical Co ltd
Original Assignee
Tianjin Kingyork Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Kingyork Pharmaceutical Co ltd filed Critical Tianjin Kingyork Pharmaceutical Co ltd
Priority to CN201910751576.4A priority Critical patent/CN112438943A/zh
Publication of CN112438943A publication Critical patent/CN112438943A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345Nitrofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12Magnesium silicate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种复方软膏,尤其是涉及一种复方鱼肝油氧化锌软膏。该药膏是由鱼肝油,氧化锌,滑石粉,呋喃西林,羊毛脂,液状石蜡和黄凡士林组成。该发明通过处方对比、筛选,能更安全有效的满足临床婴幼儿安全用药的需求。

Description

一种复方鱼肝油氧化锌软膏
技术领域
本发明涉及一种复方软膏,尤其是涉及一种复方鱼肝油氧化锌软膏。
背景技术
鱼肝油是从鲨鱼、鳕鱼等的肝脏中提炼出来的脂肪,黄色,有腥味,含有维生素A和维生素D。
氧化锌是锌的一种氧化物,难溶于水,可溶于酸和强碱。它是一种常用的化学添加剂,广泛地应用于塑料、硅酸盐制品、合成橡胶、润滑油、油漆涂料、药膏、粘合剂、食品、电池、阻燃剂等产品的制作中。
复方鱼肝油氧化锌软膏可用于治疗急慢性皮炎、湿疹、冻疮、程度较轻的烧伤、烫伤。
目前已报道的关于复方鱼肝油氧化锌软膏的文献不多。
中国专利CN 201210046360.6介绍了一种复方鱼肝油软膏和制备方法及应用。其技术方案是选取原料鱼肝油80-120份,氧化锌35-65份和乳酸依沙吖啶3.5-6.5份,配合辅料冰片,以油脂性基质为载体制备。该发明对于肛周痛痒红肿有显著疗效。
但是除了肛周痛痒疾病的治疗外,儿童用药安全也是临床需要考虑的重要因素之一。
发明内容
本发明的目的在于,针对上述问题,提供一种复方鱼肝油氧化锌软膏,该药膏通过处方对比、筛选,能更安全有效的满足临床婴幼儿安全用药的需求。
为了实现上述目的,本发明提供的复方鱼肝油氧化锌软膏,是由6-20%鱼肝油,15-25%氧化锌,3.2-3.8%滑石粉,0.09-0.13%呋喃西林,3.7-4.3%羊毛脂,7.7-8.3%液状石蜡和余量黄凡士林组成。
本发明提供的复方鱼肝油氧化锌软膏,更优选地,是将上述方案中所述鱼肝油含量控制在9-15%,氧化锌含量控制在17-23%。
上述的复方鱼肝油氧化锌软膏,所述组合物的配制方法如下:
(1)将黄凡士林加热熔化后备用;
(2)称取黄凡士林、羊毛脂加热至75℃以上,两者使用真空乳化机搅拌至均匀,保温;
(3)将处方量的氧化锌、滑石粉、呋喃西林加入真空乳化机中,搅拌均匀;
(4)真空乳化机温度在60℃以下时,将称好的鱼肝油、液状石蜡依次加入真空乳化机中,搅拌均匀成淡黄色软膏后,冷却成膏。
膏体可以灌装入铝塑管中。
由于优选了所得软膏处方,使得本发明提供的全新的复方鱼肝油氧化锌软膏更加稳定,临床安全性更好,更适宜婴幼儿使用。
具体实施方式
下面将通过实施例对本发明作进一步的描述,这些描述并不是对本发明内容作进一步的限定。本领域的技术人员应理解,对本发明的技术特征所作的等同替换,或相应的改进,仍属于本发明的保护范围之内。
实施例1
选取10%鱼肝油,17%氧化锌,3.5%滑石粉,0.1%呋喃西林,3.9%羊毛脂,7.8%液状石蜡、适量黄凡士林,共制得10Kg。
将黄凡士林加热熔化,称取黄凡士林、羊毛脂加热至75℃以上,两者使用真空乳化机搅拌至均匀;将处方量的氧化锌、滑石粉、呋喃西林加入真空乳化机中,搅拌均匀;当真空乳化机温度在60℃以下时,将称好的鱼肝油、液状石蜡依次加入真空乳化机中,搅拌均匀成淡黄色软膏后,冷却成膏。
膏体灌装入铝塑管中。
按以上配比精确称量,得到稳定性数据如下
Figure 458264DEST_PATH_IMAGE001
实施例2
选取18%鱼肝油,20%氧化锌,3.5%滑石粉,0.1%呋喃西林,3.9%羊毛脂,7.8%液状石蜡、适量黄凡士林,共制得10Kg。
将黄凡士林加热熔化,称取黄凡士林、羊毛脂加热至75℃以上,两者使用真空乳化机搅拌至均匀;将处方量的氧化锌、滑石粉、呋喃西林加入真空乳化机中,搅拌均匀;当真空乳化机温度在60℃以下时,将称好的鱼肝油、液状石蜡依次加入真空乳化机中,搅拌均匀成淡黄色软膏后,冷却成膏。
膏体灌装入铝塑管中。
按以上配比精确称量,得到稳定性数据如下
Figure 375404DEST_PATH_IMAGE002

Claims (3)

1.一种复方鱼肝油氧化锌软膏,其特征在于由6-20%鱼肝油,15-25%氧化锌,3.2-3.8%滑石粉,0.09-0.13%呋喃西林,3.7-4.3%羊毛脂,7.7-8.3%液状石蜡、和余量黄凡士林组成。
2.如权利要求1所述的一种复方鱼肝油氧化锌软膏,其特征在于所述鱼肝油含量为9-15%,氧化锌含量为17-23%。
3.如权利要求1或权利要求2所述的一种复方鱼肝油氧化锌软膏的制备方法,其特征是步骤如下:
(1)将黄凡士林加热熔化后备用;
(2)称取黄凡士林、羊毛脂加热至75℃以上,两者使用真空乳化机搅拌至均匀,保温;
(3)将处方量的氧化锌、滑石粉、呋喃西林加入真空乳化机中,搅拌均匀;
(4)真空乳化机温度在60℃以下时,将称好的鱼肝油、液状石蜡依次加入真空乳化机中,搅拌均匀成淡黄色软膏后,冷却成膏。
CN201910751576.4A 2019-08-15 2019-08-15 一种复方鱼肝油氧化锌软膏 Pending CN112438943A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910751576.4A CN112438943A (zh) 2019-08-15 2019-08-15 一种复方鱼肝油氧化锌软膏

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910751576.4A CN112438943A (zh) 2019-08-15 2019-08-15 一种复方鱼肝油氧化锌软膏

Publications (1)

Publication Number Publication Date
CN112438943A true CN112438943A (zh) 2021-03-05

Family

ID=74740902

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910751576.4A Pending CN112438943A (zh) 2019-08-15 2019-08-15 一种复方鱼肝油氧化锌软膏

Country Status (1)

Country Link
CN (1) CN112438943A (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013744A1 (en) * 2002-07-17 2004-01-22 Goulbourne Mary J. Ointment composition for treating decubitus ulcers and methods for its making and its use
CN103705538A (zh) * 2012-10-08 2014-04-09 天津金耀集团有限公司 一种氧化锌软膏

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013744A1 (en) * 2002-07-17 2004-01-22 Goulbourne Mary J. Ointment composition for treating decubitus ulcers and methods for its making and its use
CN103705538A (zh) * 2012-10-08 2014-04-09 天津金耀集团有限公司 一种氧化锌软膏

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
薛凤娟等: "复方鱼肝油氧化锌软膏治疗新生儿尿布皮炎的疗效观察", 《医学与哲学》, vol. 34, no. 8, pages 34 - 35 *
马振友等: "《皮肤美容化妆品制剂手册》", 中医古籍出版社, pages: 86 *

Similar Documents

Publication Publication Date Title
CN109628232A (zh) 一种聚甘油脂肪酸酯的制备方法
CN102212172A (zh) 一种锚固剂专用树脂及其制备方法
CN102503793A (zh) 硬脂酰苯甲酰甲烷的制备方法及在热塑性树脂成型加工中的应用
CN103467508B (zh) 甲基酮肟基甲氧基硅烷的制备方法
CN103922973A (zh) 2-丙烯酰胺基-2-甲基丙磺酸的制备方法
CN102746595A (zh) 一种利用钾离子特性掺杂改性液体金属皂热稳定剂的制备方法
CN105367728A (zh) 一种松香改性酚醛树脂及其制备方法
CN112438943A (zh) 一种复方鱼肝油氧化锌软膏
Liu et al. Characterization of triazinedithiolsilane polymeric nanofilm fabricated by galvanostatic technique on copper surface
CN106146822B (zh) 一种原油用降粘剂的制备方法
CN105585683A (zh) 一种三聚氰胺甲醛树脂絮凝剂的制备方法
CN107286588A (zh) 一种led灯专用封装材料及其制备工艺
CN104371080A (zh) 一种改性石蜡的制备方法
CN105038895B (zh) 一种安全环保燃料及其制备方法
CN107603431A (zh) 一种氨基烤漆用多功能促进剂及其制备方法
CN104448709B (zh) 一种用于文具的色母粒材料及其制备方法
CN102515613A (zh) 一种利用精萘副产物90萘制造萘系高效减水剂的方法
CN104829871B (zh) 一种白炭黑分散剂及其制备方法
CN104877510A (zh) 一种防腐抗菌油漆及其制备方法
CN107162222A (zh) 一种水处理用环保缓释长效阻垢剂
CN103897216A (zh) 一种高性能有机钴类混合盐及其制备方法
CN102351905B (zh) 一种有机硫代苄基锑化合物及其制备方法
CN106280720A (zh) 一种用于汽车收纳箱的抗氧化涂料及其制备方法
CN102746531A (zh) 钡镉锌复合稳定剂及其制备方法
CN101948417B (zh) 一种橡胶硫化促进剂二硫化二异丁基秋兰姆(TiBTD)的制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination